| Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association,Branch of Radiation Oncology Therapy, Chinese Medical Association,Professional Committee of Radiotherapy for Cancer, Chinese Anti-cancer Association,et al.Experts consensus on radiotherapy for patients with oligometastatic esophageal cancer (2025 edition)[J].Chinese Journal of Radiological Medicine and Protection,2025,45(1):1-17 |
| Experts consensus on radiotherapy for patients with oligometastatic esophageal cancer (2025 edition) |
| Received:October 14, 2024 |
| DOI：10.3760/cma.j.cn112271-20241014-00399 |
| KeyWords:Esophageal cancer Oligometastasis Radiotherapy Experts consensus |
| FundProject:中央引导地方科技发展资金项目(科技创新基地项目)(246Z7707G) |
| Author Name | Affiliation | E-mail | | Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association | | | | Branch of Radiation Oncology Therapy, Chinese Medical Association | | | | Professional Committee of Radiotherapy for Cancer, Chinese Anti-cancer Association | | | | Expert Committee of Esophageal Cancer, Chinese Cancer Radiotherapy Alliance | | | | Wang Jun | Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China | wangjun0818@hebmu.edu.cn | | Hui Zhouguang | Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China | drhuizg@163.com | | Pang Qingsong | Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China | pangqingsong@tjmuch.com |
|
| Hits: 1497 |
| Download times: 806 |
| Abstract:: |
| Approximately 40% of esophageal cancer patients have metastatic disease at the time of initial diagnosis. Although immunotherapy has changed the treatment pattern of advanced, recurrent or metastatic esophageal cancer, the options for systemic treatment for these patients are still limited, and the prognosis is poor. Oligometastasis is an intermediate stage between locoregional and widespread systemic metastasis. Some studies have shown that combining systemic treatment with local treatment, such as radiotherapy, may improve the survival of patients with oligometastasis in various solid tumors, including esophageal cancer. At present, there is still a lack of data support from large randomized clinical trials on the timing, dose, and technique of radiotherapy for oligometastatic esophageal cancer. Based on recent studies on oligometastatic esophageal cancer, this consensus was jointly developed after in-depth discussions and multiple revisions by experts from the following organizations: Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association; Branch of Radiation Oncology Therapy, Chinese Medical Association; Professional Committee of Radiotherapy for Cancer, Chinese Anti-cancer Association; Expert Committee of Esophageal Cancer, Chinese Radiation Therapy Oncology Group. This consensus provides a relatively clear definition and classification of oligometastatic esophageal cancer. It summarizes common problems in radiotherapy based on current medical evidence, to provide reference and academic guidance for the clinical practice of radiotherapy for oligometastatic esophageal cancer. |
| HTML View Full Text View/Add Comment Download reader |
| Close |
|
|
|
